#VisualAbstract: Omalizumab is superior to placebo in reducing the reaction threshold for patients with multiple food allergies

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Omalizumab efficacious in treating multiple food allergies

Early peanut introduction was not associated with lower prevalence of peanut allergy

Wellness check: Nutrition

#VisualAbstract: Omalizumab is superior to placebo in reducing the reaction threshold for patients with multiple food allergies

Omalizumab efficacious in treating multiple food allergies

Early peanut introduction was not associated with lower prevalence of peanut allergy

Wellness check: Nutrition

#VisualAbstract: RSV Prefusion F Protein-Based Maternal Vaccine Lowers Risk of Infant RSV Infection but Increases the Risk of Preterm Birth

Adding ribociclib to endocrine therapy appears to improve invasive disease-free survival in patients with early breast cancer

RelatedReports

Omalizumab efficacious in treating multiple food allergies

Early peanut introduction was not associated with lower prevalence of peanut allergy

Wellness check: Nutrition

Early exposure to allergenic foods may reduce incidence of long-term food allergy

Adding ribociclib to endocrine therapy appears to improve invasive disease-free survival in patients with early breast cancer

Venetoclax monotherapy effectively treats relapsed or refractory chronic lymphocytic leukemia

A cell-free, blood-based DNA screening test for colorectal cancer compared to colonoscopy

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits